• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem High Test Results (2457)
Patient Problem Coagulation Disorder (1779)
Event Date 10/23/2020
Event Type  Injury  
Manufacturer Narrative
The reporter's test strips were provided for investigation where they were tested using a retention meter and retention controls.Testing results with vial #1 (qc range = 2.3 - 3.5 inr): qc 1: 2.7 inr, qc 2: 2.8 inr, qc 3: 2.7 inr.Testing results with vial #2 (qc range = 2.3 - 3.5 inr): qc 1: 2.5 inr, qc 2: 2.8 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.Routine retention testing is performed.Retention testing data is reviewed and appropriate actions are taken as needed.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." the customer stated they have apa syndrome.Per product labeling, this may cause false-high inr values and false-low quick values.Where apa is known to be present, it is imperative that a result be obtained using an apa-insensitive laboratory method for comparison.Occupation was lay user/patient.
 
Event Description
The initial reporter alleged he received questionable results from coaguchek xs meter serial number (b)(4) and alleged he had a stroke due to an incorrect meter result.The meter was set to an incorrect date for the following results: on "(b)(6) 2020", the meter result was 3.2 inr.On "(b)(6) 2020", the meter result was 2.6 inr.The correct date for this result was (b)(6) 2020 at 07:01 am.On (b)(6) 2020, the customer stated his left arm and left leg gave out and an ambulance was called to transport the customer to the hospital.The laboratory result using an unknown reagent at 7:00 pm was 1.1 inr.An mri and ct scan of the brain showed a stroke ("visible clot was in brain").Examination of the carotid artery: completely occluded.The customer did not get tiaa but was put on a heparin drip.The warfarin dose was not changed.Additional information was requested but the customer was not willing to answer any additional questions.The customer stated he was currently "feeling okay".The customer stated he was diagnosed with lupus at (b)(6) years old but was not sure if has lupus antibodies.Per product labeling, "the presence of antiphospholipid antibodies (apas) such as lupus antibodies (la) can potentially lead to prolonged clotting times, i.E., they may cause false high inr values.If you have or suspect that you have apas, contact your doctor and do not continue inr testing with this device." the customer stated he was anemic, but the actual hematocrit was unknown.Per product labeling, "hematocrit ranges between 25-55% do not significantly affect results." generally, in the case of anemia / severe anemia, you should not take anticoagulation dosage decisions based on meter results.The therapeutic range was 2.5-3.5 inr and the customer tests once a week.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key10901405
MDR Text Key218219452
Report Number1823260-2020-03011
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2021
Device Catalogue Number04625374160
Device Lot Number43002022
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/16/2020
Initial Date Manufacturer Received 10/29/2020
Initial Date FDA Received11/25/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LIPITOR.; METOPROLOL.; WARFARIN.
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient Weight77
-
-